Sonnet BioTherapeutics Holdings Inc (SONN)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End September 29 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -23.984 | -21.684 | -23.253 | -58.178 | -331.945 | -135.092 | -170.698 | -334.541 |
| Return on Equity (%) | -51.702 | -55.569 | -70.627 | -698.883 | 99400 | -197.658 | -301.425 | 1362.242 |
| Return on Invested Capital (%) | -13.083 | -20.723 | -29.64 | -218.309 | 5240.043 | -198.152 | -302.621 | 1124.656 |
| Operating Margin (%) | -4.319 | -12.591 | -13.229 | -55.386 | N/A | -5161.983 | -8492 | -12725 |
| Net Profit Margin (%) | -21.766 | -16.661 | -17.169 | -59.181 | N/A | -5161.983 | -8492 | -12725 |
| Book Value Per Share | -0.261 | -2.316 | -2.193 | -1.478 | 0.205 | 0.369 | -0.458 | -0.006 |
| Earnings Per Share | -0.424 | -2.266 | -1.877 | -1.715 | -4.456 | -0.415 | -5.36 | -0.489 |
| Cash Per Share | 0.013 | 0.09 | 0.17 | 0.048 | 0.499 | 0.458 | 0.551 | 0.059 |
| Working Capital Per Share | -0.482 | -4.303 | -3.402 | -1.627 | 0.198 | 0.367 | -0.496 | -0.02 |
| Operating Profit Per Share | 1.323 | 9.107 | 7.356 | 2.021 | N/A | 0.008 | 0.063 | 0.004 |
| EBIT Per Share | -0.194 | -2.564 | -2.127 | -1.669 | -1.648 | -0.415 | -5.36 | -0.489 |
| EBITDA Per Share | -0.194 | -2.564 | -2.127 | -1.669 | -1.648 | -0.415 | -5.36 | -0.489 |
| Free Cash Flow Per Share | -0.478 | -2.482 | -1.815 | -1.882 | -4.451 | -0.415 | -5.201 | -0.478 |
| Year End September 29 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 21.39M | 3.05M | 3.72M | 10.4M | 14.72M | 60.25M | 5.55M | N/A |
| Year End September 29 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 5.55M | 7.96M | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | -14978.378 | N/A | N/A | N/A | -6152.632 | N/A | N/A |
| Net Profit Margin (%) | N/A | -14978.378 | N/A | N/A | N/A | -6152.632 | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 3.97M |
| Price to Earnings Ratio | -0.2 |
| Price to Sales Ratio | 25.97 |
| Price to Cash Ratio | 1.69 |
| Price to Book Ratio | -17.01 |
| Dividend Yield | - |
| Shares Outstanding | 650.31k |
| Average Volume (1 week) | 47.2k |
| Average Volume (1 Month) | 63.79k |
| 52 Week Change | 136.40% |
| 52 Week High | 6.96 |
| 52 Week Low | 0.6239 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
